These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8234700)

  • 1. Cost containment in the use of low-osmolar contrast agents: effect of guidelines, monitoring, and feedback mechanisms.
    Levin DC; Gardiner GA; Karasick S; Shaber GS; Wechsler RJ; McArdle GH; Lockard CD; Harford RJ
    Radiology; 1993 Dec; 189(3):753-7. PubMed ID: 8234700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective use of low-osmolality contrast agents for i.v. urography and CT: safety and effect on cost.
    Hunter TB; Dye J; Duval JF
    AJR Am J Roentgenol; 1994 Oct; 163(4):965-8. PubMed ID: 8092044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-effectiveness of replacing high-osmolality with low-osmolality contrast media.
    Caro JJ; Trindade E; McGregor M
    AJR Am J Roentgenol; 1992 Oct; 159(4):869-74. PubMed ID: 1529856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indications for the use of low-osmolar contrast agents.
    Bloom DM
    Physician Exec; 1989; 15(4):24-5. PubMed ID: 10313370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospitals begin cutting non-ionic contrast agent use.
    Werner C
    Hosp Mater Manage; 1993 Oct; 18(10):1, 11-2. PubMed ID: 10129785
    [No Abstract]   [Full Text] [Related]  

  • 6. Adverse events with radiographic contrast agents: results of the SCVIR Contrast Agent Registry.
    Bettmann MA; Heeren T; Greenfield A; Goudey C
    Radiology; 1997 Jun; 203(3):611-20. PubMed ID: 9169677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness and safety of selective use of low-osmolality contrast media.
    Michalson A; Franken EA; Smith W
    Acad Radiol; 1994 Sep; 1(1):59-62. PubMed ID: 9419466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of imaging agents underscores extent of battle to control costs.
    Scott L
    Mod Healthc; 1994 Mar; 24(13):42. PubMed ID: 10132357
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cost analysis of contrast-enhanced cranial MRI at a German university hospital].
    Schreyer AG; Friedrich C; Mrosek S; Hoffstetter P; Rennert J; Framme C; Jung EM; Feuerbach S; Schöffski O; Zorger N
    Rofo; 2010 Oct; 182(10):891-9. PubMed ID: 20563960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low osmolar (non-ionic) contrast media versus high osmolar (ionic) contrast media in intravenous urography and enhanced computerized tomography: a cost-effectiveness analysis.
    Wangsuphachart S
    Southeast Asian J Trop Med Public Health; 1991 Dec; 22(4):664-76. PubMed ID: 1820658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and severity of adverse effects of iodinated and gadolinium contrast materials: retrospective review of 456,930 doses.
    Hunt CH; Hartman RP; Hesley GK
    AJR Am J Roentgenol; 2009 Oct; 193(4):1124-7. PubMed ID: 19770337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safe administration of contrast media: what do physicians know?
    Confino-Cohen R; Goldberg A
    Ann Allergy Asthma Immunol; 2004 Aug; 93(2):166-70. PubMed ID: 15328677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for use of low-osmolality contrast agents.
    Bettmann MA
    Radiology; 1989 Sep; 172(3 Pt 2):901-3. PubMed ID: 2672104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-osmolality contrast media: good news or bad?
    Evens RG
    Radiology; 1988 Oct; 169(1):277-8. PubMed ID: 3138706
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety and cost effectiveness of high-osmolality as compared with low-osmolality contrast material in patients undergoing cardiac angiography.
    Steinberg EP; Moore RD; Powe NR; Gopalan R; Davidoff AJ; Litt M; Graziano S; Brinker JA
    N Engl J Med; 1992 Feb; 326(7):425-30. PubMed ID: 1732769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High and low osmolar contrast media: who pays?
    Göthlin JH
    Eur J Radiol; 1988 May; 8(2):67-8. PubMed ID: 3383859
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravenous use of ionic and nonionic contrast agents in children.
    Cohen MD; Smith JA
    Radiology; 1994 Jun; 191(3):793-4. PubMed ID: 8184066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast medium-induced adverse reactions: economic outcome.
    Powe NR; Steinberg EP; Erickson JE; Moore RD; Smith CR; White RI; Brinker JA; Fishman EK; Zinreich SJ; Kinnison ML
    Radiology; 1988 Oct; 169(1):163-8. PubMed ID: 3420254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced use of lower-osmolality contrast media resulting from an order form and guidelines.
    Swanson DP; Damiani-Hieronim DR; Baron RL
    Am J Hosp Pharm; 1994 Dec; 51(23):2952-5. PubMed ID: 7879806
    [No Abstract]   [Full Text] [Related]  

  • 20. The safety and cost-effectiveness of low osmolar contrast media. Can economic analysis determine the real worth of a new technology?
    Henry DA; Evans DB; Robertson J
    Med J Aust; 1991 Jun; 154(11):766-72. PubMed ID: 1828529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.